Home › Triple-Negative Breast Cancer › Connecticut › Bridgeport
Triple-Negative Breast Cancer clinical trials in Bridgeport, CT
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Bridgeport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- Stony Brook Medicine, Stony Brook · 18 mi away
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
RecruitingEarly phase 1
- Stony Brook Breast Center, Stony Brook · 18 mi away
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RecruitingObservational study
- Stony Brook University Cancer Center, Stony Brook · 18 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Bridgeport
- Breast Cancer21 studies
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Cardiovascular Disease9 studies
- Cancer (all types)8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Brain Aneurysm6 studies
- Multiple Myeloma6 studies
- Prostate Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.